What to know about the Johnson and Johnson Vaccine Pause
Federal officials recently called for an immediate “pause” in distribution of the Johnson & Johnson COVID-19 vaccine after six people — all women between the ages of 18 and 48 — developed a rare blood-clot disorder within two weeks of receiving the vaccine. One of the women died, and a second has been hospitalized in critical condition. As a result, and because doctors may need more information as to how to treat this extremely rare condition should it occur, federal officials have recommended the pause.